These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 902377)
1. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure. Mikulic E; Cohn JN; Franciosa JA Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery. Pomer S; Elert O; Sarai K; Satter P Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):77-81. PubMed ID: 3957495 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy--a comparative study with dobutamine and sodium nitroprusside. Baumann G; Felix S; Sattelberger U; Klein G J Cardiovasc Pharmacol; 1990 Jul; 16(1):93-100. PubMed ID: 1696672 [TBL] [Abstract][Full Text] [Related]
4. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure. Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585 [TBL] [Abstract][Full Text] [Related]
5. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure. Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603 [No Abstract] [Full Text] [Related]
6. Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin. Sabbah HN; Levine TB; Gheorghiade M; Kono T; Goldstein S Cardiovasc Drugs Ther; 1993 Jun; 7(3):349-56. PubMed ID: 8395876 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic equivalence of automated nitroglycerin- and nitroprusside-infusions combined with dobutamine for augmentation of cardiac output in patients following aorta coronary bypass-operation. Pomer S; Sarai K; Krause E; Satter P Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):602-7. PubMed ID: 6437993 [TBL] [Abstract][Full Text] [Related]
8. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [TBL] [Abstract][Full Text] [Related]
9. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions. Stemple DR; Kleiman JH; Harrison DC Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839 [TBL] [Abstract][Full Text] [Related]
10. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Leier CV; Webel J; Bush CA Circulation; 1977 Sep; 56(3):468-72. PubMed ID: 884803 [TBL] [Abstract][Full Text] [Related]
11. Circulatory response to vasodilator therapy in congestive cardiomyopathy. Rossen RM; Alderman EL; Harrison DC Br Heart J; 1976 Jul; 38(7):695-700. PubMed ID: 973893 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure. Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440 [TBL] [Abstract][Full Text] [Related]
13. Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction. Miller RR; Awan NA; Joye JA; Maxwell KS; DeMaria AN; Amsterdam EA; Mason DT Circulation; 1977 Jun; 55(6):881-4. PubMed ID: 858184 [TBL] [Abstract][Full Text] [Related]
14. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. Packer M; Meller J; Medina N; Yushak M Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876 [TBL] [Abstract][Full Text] [Related]
15. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070 [TBL] [Abstract][Full Text] [Related]
16. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Leier CV; Heban PT; Huss P; Bush CA; Lewis RP Circulation; 1978 Sep; 58(3 Pt 1):466-75. PubMed ID: 679437 [TBL] [Abstract][Full Text] [Related]
17. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside. Massie BM; Cornyn J; Topic N; Loge D; Podolin RA Am J Cardiol; 1987 Sep; 60(8):647-53. PubMed ID: 3661429 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure. Franciosa JA; Cohn JN Am J Cardiol; 1979 Jan; 43(1):79-85. PubMed ID: 758774 [No Abstract] [Full Text] [Related]
19. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Loeb HS; Bredakis J; Gunner RM Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933 [TBL] [Abstract][Full Text] [Related]
20. Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure. Coddens J; Delooft T; Vandenbroucke G J Cardiothorac Vasc Anesth; 1993 Jun; 7(3):321-5. PubMed ID: 8518380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]